Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-08

Clinical Trial Update: Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining genotypic resistance-guided therapy for Helicobacter pylori eradication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Self Efficacy | Phase 4 | Status: UNKNOWN